[Toxicity of microcystin and its bioaccumulation effect]

Haixia Sui1, Weixing Yan, Haibin Xu

  • 1Institute of Food Safety Control and Inspection, Ministry of Health, Beijing 100021, China.

Insights

Microcystins, potent cyanobacterial toxins, inhibit liver enzymes, causing damage and promoting tumors. This review details their toxicity and bioaccumulation, highlighting understudied hazards.

Area of Science:

  • Environmental toxicology
  • Biochemistry

Context:

  • Cyanobacteria produce microcystins, potent cyclic heptapeptide hepatotoxins.
  • These toxins target hepatic protein phosphatase 1 and 2A, disrupting cellular signaling.
  • Microcystins are known carcinogens and tumor promoters.

Purpose:

  • To review the latest research on microcystin toxicity.
  • To examine the bioaccumulation of microcystins in organisms.
  • To highlight the understudied risks associated with microcystins.

Summary:

  • Microcystins inhibit key liver enzymes, leading to cellular damage and necrocytosis.
  • The disruption of protein phosphorylation/dephosphorylation balance contributes to liver injury.
  • Evidence suggests microcystins act as potent tumor promoters.

Impact:

  • Increased understanding of microcystin-induced liver damage.
  • Highlights the need for further research into microcystin bioaccumulation and long-term health effects.
  • Provides a comprehensive overview for toxicologists and environmental health professionals.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Microbial Leaching01:27

Microbial Leaching

Microbial leaching, also known as bioleaching, is an environmentally favorable method for extracting metals from low-grade ores using specific microorganisms. This biotechnological approach is particularly valuable for mining operations targeting copper, gold, and uranium, where traditional extraction methods may be economically or environmentally impractical.Copper Leaching and Microbial CatalysisIn copper bioleaching, crushed ore is arranged into heaps and irrigated with a dilute sulfuric...
Microbial Bioremediation of Uranium01:25

Microbial Bioremediation of Uranium

Microorganisms play a critical role in the transformation and immobilization of uranium in contaminated environments through four main pathways: bioreduction, biosorption, bioaccumulation, and biomineralization. These mechanisms reduce uranium’s toxicity and prevent its migration through groundwater systems, offering sustainable approaches for in situ bioremediation.Bioreduction of UraniumBioreduction is driven by anaerobic bacteria such as certain strains of Geobacter and Shewanella, which use...